Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0248 | 0.5139 | 0.5139 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0348 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0248 | 0.5139 | 0.4279 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.6913 | 0.6913 |
Onchocerca volvulus | 0.0284 | 0.6913 | 0.6913 | |
Echinococcus granulosus | tissue type plasminogen activator | 0.0348 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.1547 | 0.1547 |
Schistosoma mansoni | hypothetical protein | 0.0348 | 1 | 1 |
Brugia malayi | Muscle positioning protein 4 | 0.0284 | 0.6913 | 0.6913 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0348 | 1 | 1 |
Onchocerca volvulus | 0.0248 | 0.5139 | 0.5139 | |
Loa Loa (eye worm) | hypothetical protein | 0.0348 | 1 | 1 |
Toxoplasma gondii | kringle domain-containing protein | 0.0348 | 1 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0348 | 1 | 0.5 |
Onchocerca volvulus | 0.0348 | 1 | 1 | |
Brugia malayi | SEA domain containing protein | 0.0248 | 0.5139 | 0.5139 |
Loa Loa (eye worm) | hypothetical protein | 0.0248 | 0.5139 | 0.5139 |
Onchocerca volvulus | 0.0248 | 0.5139 | 0.5139 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0348 | 1 | 0.5 |
Brugia malayi | Kringle domain containing protein | 0.0348 | 1 | 1 |
Onchocerca volvulus | 0.0248 | 0.5139 | 0.5139 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0348 | 1 | 0.5 |
Onchocerca volvulus | 0.0248 | 0.5139 | 0.5139 | |
Leishmania major | hypothetical protein, conserved | 0.0348 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.834 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.808 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.789 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.773 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.719 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.696 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.672 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.635 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.633 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.548 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.527 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.